Format

Send to

Choose Destination
Clin Microbiol Infect. 2008 Jul;14(7):727-30. doi: 10.1111/j.1469-0691.2008.02021.x.

In vitro susceptibility of Cryptococcus gattii clinical isolates.

Author information

1
Servicio de MicologĂ­a, Centro Nacional de MicrobiologĂ­a, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain.aliciagl@isciii.es

Abstract

The data available in the literature concerning Cryptococcus gattii in vitro antifungal susceptibility are contradictory. We have analyzed the activity of eight antifungal agents against 23 C. gattii clinical isolates and compared the susceptibility profiles with those of C. neoformans. MIC analysis (mg/L) revealed that C. gattii isolates were more susceptible to amphotericin B and flucytosine than were C. neoformans isolates. Fluconazole and other azole compounds showed high MIC values for C. gattii. Posaconazole displayed good activity. Further studies are required to ascertain the predictive value of the in vitro data presented here.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center